Summit Trail Advisors, LLC Bio N Tech Se Transaction History

Summit Trail Advisors, LLC

  • $3.71 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$126.25 - $231.85 $117,286 - $215,388
-929 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$216.64 - $362.52 $27,946 - $46,765
129 Added 16.13%
929 $239,000
Q3 2021

Nov 16, 2021
SELL
$205.93 - $447.23 $51,482 - $111,807
-250 Reduced 23.81%
800 $218,000
Q2 2021

Aug 16, 2021
BUY
$113.32 - $241.49 $118,986 - $253,564
1,050 New
1,050 $235,000

Others Institutions Holding BNTX

# of Institutions
327
Shares Held
40.4M
Call Options Held
1.31M
Put Options Held
1.37M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $19.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email